These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35352756)

  • 21. Retinal nerve fiber and ganglion cell complex layer thicknesses mirror brain atrophy in patients with relapsing-remitting multiple sclerosis.
    Glasner P; Sabisz A; Chylińska M; Komendziński J; Wyszomirski A; Karaszewski B
    Restor Neurol Neurosci; 2022; 40(1):35-42. PubMed ID: 35180139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases.
    Cabrera DeBuc D; Somfai GM; Koller A
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H201-H212. PubMed ID: 27923786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Coherence Tomography Angiography: A Window into Central Nervous System Neurodegeneration.
    Shah A; Apte RS
    Trends Mol Med; 2020 Oct; 26(10):892-895. PubMed ID: 32868169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Effect of Panretinal Photocoagulation on Spectral Domain Optical Coherence Tomography Measurements in Diabetic Retinopathy.
    Lee HJ; Kang TS; Kwak BS; Jo YJ; Kim JY
    Curr Eye Res; 2017 Aug; 42(8):1169-1173. PubMed ID: 28339297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical coherence tomography: a window to the optic nerve in clinically isolated syndrome.
    London F; Zéphir H; Drumez E; Labreuche J; Hadhoum N; Lannoy J; Hodel J; Vermersch P; Pruvo JP; Leclerc X; Outteryck O
    Brain; 2019 Apr; 142(4):903-915. PubMed ID: 30847470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of optical coherence tomography in the evaluation of compressive optic neuropathies.
    Micieli JA; Newman NJ; Biousse V
    Curr Opin Neurol; 2019 Feb; 32(1):115-123. PubMed ID: 30418197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients.
    Cifuentes-Canorea P; Ruiz-Medrano J; Gutierrez-Bonet R; Peña-Garcia P; Saenz-Frances F; Garcia-Feijoo J; Martinez-de-la-Casa JM
    PLoS One; 2018; 13(4):e0196112. PubMed ID: 29672563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
    Saidha S; Syc SB; Ibrahim MA; Eckstein C; Warner CV; Farrell SK; Oakley JD; Durbin MK; Meyer SA; Balcer LJ; Frohman EM; Rosenzweig JM; Newsome SD; Ratchford JN; Nguyen QD; Calabresi PA
    Brain; 2011 Feb; 134(Pt 2):518-33. PubMed ID: 21252110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Optical Coherence Tomography in optic neuropathies.
    Iorga RE; Moraru A; Ozturk MR; Costin D
    Rom J Ophthalmol; 2018; 62(1):3-14. PubMed ID: 29796429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of optical coherence tomography in neurology.
    Lamirel C; Newman N; Biousse V
    Rev Neurol Dis; 2009; 6(4):E105-20. PubMed ID: 20065921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis.
    Tan O; Li G; Lu AT; Varma R; Huang D;
    Ophthalmology; 2008 Jun; 115(6):949-56. PubMed ID: 17981334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.
    Syc SB; Saidha S; Newsome SD; Ratchford JN; Levy M; Ford E; Crainiceanu CM; Durbin MK; Oakley JD; Meyer SA; Frohman EM; Calabresi PA
    Brain; 2012 Feb; 135(Pt 2):521-33. PubMed ID: 22006982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Capability of 3D Peripapillary Retinal Volume for Glaucoma Using Optical Coherence Tomography Customized Software.
    Liu Y; Jassim F; Braaf B; Khoueir Z; Poon LY; Ben-David GS; Papadogeorgou G; Tsikata E; Simavli H; Que C; Lee R; Shieh E; Vakoc BJ; Bouma BE; de Boer JF; Chen TC
    J Glaucoma; 2019 Aug; 28(8):708-717. PubMed ID: 31180936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging retinal structures at cellular-level resolution by visible-light optical coherence tomography.
    Pi S; Hormel TT; Wei X; Cepurna W; Morrison JC; Jia Y
    Opt Lett; 2020 Apr; 45(7):2107-2110. PubMed ID: 32236080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical coherence tomography--current and future applications.
    Adhi M; Duker JS
    Curr Opin Ophthalmol; 2013 May; 24(3):213-21. PubMed ID: 23429598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precision of Optic Nerve Head and Retinal Nerve Fiber Layer Parameter Measurements by Spectral-domain Optical Coherence Tomography.
    Schrems-Hoesl LM; Schrems WA; Laemmer R; Kruse FE; Mardin CY
    J Glaucoma; 2018 May; 27(5):407-414. PubMed ID: 29329141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography.
    Khanifar AA; Parlitsis GJ; Ehrlich JR; Aaker GD; D'Amico DJ; Gauthier SA; Kiss S
    Clin Ophthalmol; 2010 Sep; 4():1007-13. PubMed ID: 20922034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of Heidelberg retinal tomography and spectral domain optical coherence tomography examinations for detection of glaucoma].
    Piasecka K; Bednarski M; Nawrocka Z; Nawrocki J; Michalewska Z
    Klin Oczna; 2013; 115(2):125-9. PubMed ID: 24059028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glaucoma diagnostic value of the total macular thickness and ganglion cell-inner plexiform layer thickness according to optic disc area.
    Yoon MH; Park SJ; Kim CY; Chin HS; Kim NR
    Br J Ophthalmol; 2014 Mar; 98(3):315-21. PubMed ID: 24385290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy.
    Yamada Y; Himeno T; Tsuboi K; Shibata Y; Kawai M; Asada-Yamada Y; Hayashi Y; Asano-Hayami E; Hayami T; Ishida Y; Ejima Y; Motegi M; Asano S; Kato M; Nagao E; Nakai-Shimoda H; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Nakayama T; Kamei M; Nakamura J; Kamiya H
    J Diabetes Investig; 2021 Aug; 12(8):1430-1441. PubMed ID: 33300294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.